Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
Maria Røed Skårderud, Anne Polk, Kirsten Kjeldgaard Vistisen, Finn Ole Larsen,
Dorte Lisbet Nielsen
Department of Clinical Medicine
30
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
28%
Clinical Biomarkers
14%
Clinical Data
14%
Colorectal Cancer
14%
Conference Abstracts
14%
Embase
14%
Hazard Ratio
28%
Hypertension
14%
Meta-analysis
28%
Metastatic Colorectal Cancer (mCRC)
100%
Molecular Biomarkers
14%
Multi-targeted Tyrosine Kinase Inhibitors
14%
Nonrandomized Studies
14%
Overall Survival
28%
Overall Survival Progression-free Survival
14%
Patient Selection
14%
Phase II Trial
14%
Placebo
42%
Previously Treated
14%
Progression-free Survival
28%
PubMed
14%
Randomized Phase III Trial
28%
Survival Benefit
14%
Treatment Effect
14%
Treatment Options
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hand Foot Syndrome
14%
Regorafenib
100%